Financials

  • Market Capitalization 637.69 M
  • Employee 371
  • Founded 2008
  • CEO N/A
  • Website www.regenxbio.com
  • Headquarter Maryland, United States
  • FIGI BBG007Z9V591
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.83
Rapporto prezzo/fatturato
4.36

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2750
VSTM
Verastem, Inc. - Common Stock
7.22 USD-2.17%+4.64%+21.96%-19.78%653.87 M USD
2756
CRMD
CorMedix Inc. - Common Stock
8.30 USD-0.12%+0.73%+14.01%-26.55%646.94 M USD
2768
SLN
Silence Therapeutics Plc - American Depository Share
13.42 USD-0.22%-0.59%+16.09%+173.88%634.05 M USD
2779
HELP
Cybin Inc. - Common Stock
12.18 USD-8.01%-2.64%+54.18%+35.79%628.88 M USD

Notizie